Erenumab is a fully human monoclonal antibody designed to selectively target and inhibit the calcitonin gene-related peptide (CGRP) receptor. This inhibition is crucial for the prevention of episodic migraine, as it interferes with the pathway believed to play a key role in the initiation of migraine episodes. Erenumab is specifically developed for prophylactic applications, offering a therapeutic approach for patients suffering from frequent migraine attacks.
Erenumab is a fully human monoclonal antibody designed to selectively target and inhibit the calcitonin gene-related peptide (CGRP) receptor. This inhibition is crucial for the prevention of episodic migraine, as it interferes with the pathway believed to play a key role in the initiation of migraine episodes. Erenumab is specifically developed for prophylactic applications, offering a therapeutic approach for patients suffering from frequent migraine attacks.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
